论文部分内容阅读
自阿苯达唑、吡喹酮问世以来,对脑囊虫病的治疗多为单独用药。为了提高其近期治愈率,并减轻治疗中的副反应,我们对46例脑囊虫病人采用了先投阿苯达唑,后投吡喹酮的治疗方法,并于2疗程后半年以上进行复查。现将观察结果报告如下: 一、临床资料本组46例中男34例、女12例;年龄8～56岁,平均34岁;病程10d～17年,平均2.5年。46例中有颞癫发作者35例(76.09％),其中大发作32例,小发作1例,局限性发作2例。间歇性发热3例(6.52％)。头痛、头晕37例(80.43％),恶心8例(17.39％),伴呕吐6例
Since the advent of albendazole, praziquantel since the advent of the treatment of cerebral cysticercosis and more for the single drug. In order to improve its recent cure rate and reduce the side effects of treatment, 46 patients with neurocysticercosis were treated with albendazole and praziquantel after the first course of treatment, and were reviewed after more than half a year of treatment. The observation results are reported as follows: First, the clinical data of 46 cases in this group, 34 males and 12 females; aged 8 to 56 years, mean 34 years; duration of 10d ~ 17 years, an average of 2.5 years. Of the 46 cases, 35 (76.09%) had temporal epilepsy, of which 32 were major, 1 were minor, and 2 were localized. Intermittent fever in 3 cases (6.52%). Headache, dizziness in 37 cases (80.43%), nausea in 8 cases (17.39%), with vomiting in 6 cases